1093 N logo

CSPC Pharmaceutical Group BMV:1093 N Stock Report

Last Price

Mex$15.69

Market Cap

Mex$151.7b

7D

0%

1Y

-27.0%

Updated

12 Feb, 2024

Data

Company Financials +

CSPC Pharmaceutical Group Limited

BMV:1093 N Stock Report

Market Cap: Mex$151.7b

1093 N Stock Overview

An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People’s Republic of China, other Asian regions, North America, Europe, and internationally. More details

1093 N fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance3/6
Financial Health6/6
Dividends3/6

Rewards

Trading at 38.8% below our estimate of its fair value

Earnings have grown 14.6% per year over the past 5 years

Risk Analysis

Shares are highly illiquid

Dividend of 4.75% is not well covered by cash flows


My Notes

Capture your thoughts, links and company narrative

CSPC Pharmaceutical Group Limited Competitors

Genomma Lab Internacional. de

BMV:LAB B

Mex$24.1b

Aurobindo Pharma

NSEI:AUROPHARMA

₹733.2b

Ipsen

ENXTPA:IPN

€8.9b

Beijing Tongrentang

SHSE:600085

CN¥57.0b

Price History & Performance

Summary of share price highs, lows and changes for CSPC Pharmaceutical Group
Historical stock prices
Current Share PriceHK$15.69
52 Week HighHK$15.69
52 Week LowHK$15.69
Beta0.71
1 Month Change0%
3 Month Changen/a
1 Year Change-27.02%
3 Year Changen/a
5 Year Changen/a
Change since IPO-41.10%

Recent News & Updates

Recent updates

Shareholder Returns

1093 NMX PharmaceuticalsMX Market
7D0%0.2%-3.2%
1Y-27.0%-25.3%-14.3%

Return vs Industry: 1093 N matched the MX Pharmaceuticals industry which returned -27.6% over the past year.

Return vs Market: 1093 N underperformed the MX Market which returned 6.4% over the past year.

Price Volatility

Is 1093 N's price volatile compared to industry and market?
1093 N volatility
1093 N Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement6.6%
Market Average Movement4.1%
10% most volatile stocks in MX Market6.0%
10% least volatile stocks in MX Market2.7%

Stable Share Price: 1093 N has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine 1093 N's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
199225,587Cuilong Zhangwww.cspc.com.hk

CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People’s Republic of China, other Asian regions, the Americas, Europe, and internationally. The company operates through Finished Drugs, Bulk Products, and Functional Food and Others segments. It provides NBP soft capsules and injections for acute ischemic stroke; Oulaining capsules and injections to treat mild to moderate memory and mental impairment; Enxi to treat adult idiopathic Parkinson’s disease; Duomeisu for lymphoma, multiple myeloma, ovarian and breast cancers, and other malignant tumors; Jinyouli to prevent leucopenia and infection induced by chemotherapy; and Keaili for breast cancer.

CSPC Pharmaceutical Group Limited Fundamentals Summary

How do CSPC Pharmaceutical Group's earnings and revenue compare to its market cap?
1093 N fundamental statistics
Market capMex$151.69b
Earnings (TTM)Mex$14.61b
Revenue (TTM)Mex$74.74b

10.4x

P/E Ratio

2.0x

P/S Ratio

Is 1093 N overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1093 N income statement (TTM)
RevenueCN¥31.31b
Cost of RevenueCN¥9.34b
Gross ProfitCN¥21.97b
Other ExpensesCN¥15.85b
EarningsCN¥6.12b

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.52
Gross Margin70.17%
Net Profit Margin19.54%
Debt/Equity Ratio1.2%

How did 1093 N perform over the long term?

See historical performance and comparison

Dividends

4.7%

Current Dividend Yield

44%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/02/12 01:42
End of Day Share Price 2023/11/15 00:00
Earnings2023/09/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

CSPC Pharmaceutical Group Limited is covered by 50 analysts. 27 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Wai Chak YuenBOCI Research Ltd.
Sharon ShiBOCI Research Ltd.
Ethan CuiBofA Global Research